Nayak Manel D, Thaker S, Vasudevan G, Menon G
J Med Case Rep. 2025; 19(1):78.
PMID: 40016832
PMC: 11866880.
DOI: 10.1186/s13256-025-05083-8.
Gui C, Canthiya L, Zadeh G, Suppiah S
Neurooncol Adv. 2024; 6(Suppl 3):iii83-iii93.
PMID: 39430389
PMC: 11485951.
DOI: 10.1093/noajnl/vdae067.
Bashiri F, Hundallah K, Abukhaled M, Alyahya M, Al Futaisi A, Alshowaeir D
Front Oncol. 2024; 14:1323176.
PMID: 39257551
PMC: 11385870.
DOI: 10.3389/fonc.2024.1323176.
Botero V, Tomchik S
J Neurodev Disord. 2024; 16(1):49.
PMID: 39217323
PMC: 11365184.
DOI: 10.1186/s11689-024-09565-6.
Lima I, Fatima Marques de Moraes L, Fonseca C, Llerena Junior J, Mehrjouy M, Tommerup N
Mol Cytogenet. 2024; 17(1):15.
PMID: 38992676
PMC: 11241779.
DOI: 10.1186/s13039-024-00684-2.
Visual Deficits and Diagnostic and Therapeutic Strategies for Neurofibromatosis Type 1: Bridging Science and Patient-Centered Care.
Miyagishima K, Qiao F, Stasheff S, Nadal-Nicolas F
Vision (Basel). 2024; 8(2).
PMID: 38804352
PMC: 11130890.
DOI: 10.3390/vision8020031.
Contemporary Approach to Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.
Hirbe A, Dehner C, Dombi E, Eulo V, Gross A, Sundby T
Am Soc Clin Oncol Educ Book. 2024; 44(3):e432242.
PMID: 38710002
PMC: 11656191.
DOI: 10.1200/EDBK_432242.
Functional and Radiological Outcomes of All-Posterior Surgical Correction of Dystrophic Curves in Patients with Neurofibromatosis Type 1.
Shetty A, Meena J, Murugan C, Milton R, Kanna R, Rajasekaran S
Asian Spine J. 2024; 18(2):174-181.
PMID: 38454755
PMC: 11065515.
DOI: 10.31616/asj.2023.0294.
The efficacy of statins for improving cognitive impairments in pediatric patients with neurofibromatosis type 1 (NF-1): a meta-analysis.
Gan L, Zhu W, Fu P
Front Pediatr. 2023; 11:1274972.
PMID: 37876519
PMC: 10591081.
DOI: 10.3389/fped.2023.1274972.
Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment.
Miller A, Halloran M
Dis Model Mech. 2022; 15(8).
PMID: 36037004
PMC: 9459395.
DOI: 10.1242/dmm.049422.
Bibliometric analysis of the top 100 most-cited articles in neurofibromatosis.
Alnefaie N, Almutairi O, Alturki A, Bafaquh M
Surg Neurol Int. 2022; 13:282.
PMID: 35855179
PMC: 9282785.
DOI: 10.25259/SNI_114_2022.
Gene Alterations Define Specific Features of a Subset of Glioblastomas.
Scheer M, Leisz S, Sorge E, Storozhuk O, Prell J, Ho I
Int J Mol Sci. 2022; 23(1).
PMID: 35008787
PMC: 8745708.
DOI: 10.3390/ijms23010352.
Neurofibromin Deficiency Causes Epidermal Growth Factor Receptor Upregulation through the Activation of Ras/ERK/SP1 Signaling Pathway in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheet Tumor.
Park G, Lee S, Lee C, Kim J, Park E, Jeong S
Int J Mol Sci. 2021; 22(24).
PMID: 34948100
PMC: 8706697.
DOI: 10.3390/ijms222413308.
A 63-kg giant neurofibroma in the right lower extremity and gluteal region of a 22-year-old woman: A case report.
Sharma S, Pokhrel B, Khadka N, Rayamajhi S, Shrestha J, Lohani I
Clin Case Rep. 2021; 9(6):e04152.
PMID: 34194752
PMC: 8222651.
DOI: 10.1002/ccr3.4152.
Features of CT and EUS in mesenteric plexiform neurofibroma with Neurofibromatosis type I: A case report.
Li Y, Chen H, Ding X, Wu Q, Guo Q, Hu D
Radiol Case Rep. 2021; 16(8):2103-2107.
PMID: 34158903
PMC: 8203574.
DOI: 10.1016/j.radcr.2021.04.071.
Genetic variations in medical research in the past, at present and in the future.
Kamatani Y, Nakamura Y
Proc Jpn Acad Ser B Phys Biol Sci. 2021; 97(6):324-335.
PMID: 34121043
PMC: 8403528.
DOI: 10.2183/pjab.97.018.
Mutational spectrum of NF1 gene in 24 unrelated Egyptian families with neurofibromatosis type 1.
Abdel-Aziz N, El-Kamah G, A Khairat R, R Mohamed H, Gad Y, El-Ghor A
Mol Genet Genomic Med. 2021; 9(12):e1631.
PMID: 34080803
PMC: 8683698.
DOI: 10.1002/mgg3.1631.
Characterization of Two Loss-of-Function NF1 Variants in Chinese Patients and Potential Molecular Interpretations of Phenotypes.
Zhang T, Han T, Dong Z, Li C, Lu W
Front Genet. 2021; 12:660592.
PMID: 34046057
PMC: 8144720.
DOI: 10.3389/fgene.2021.660592.
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.
Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery R, Berman Y
Genet Med. 2021; 23(8):1506-1513.
PMID: 34012067
PMC: 8354850.
DOI: 10.1038/s41436-021-01170-5.
Neurofibromatosis Type 1 with Severe Dystrophic Kyphosis: Surgical Treatment and Prognostic Analysis of 27 Patients.
Cai S, Tian Y, Qiu G, Zhang J, Shen J, Zhao H
Orthop Surg. 2020; 12(6):1923-1940.
PMID: 33184974
PMC: 7767777.
DOI: 10.1111/os.12848.